Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Sci Signal. 2012 Oct 23;5(247):ra77. doi: 10.1126/scisignal.2003199.
The Polycomb group protein Bmi1 is a transcriptional silencer of the Ink4a-Arf locus, which encodes the cell cycle regulator p16(Ink4a) and the tumor suppressor p19(Arf). Bmi1 plays a key role in oncogenesis and stem cell self-renewal. We report that phosphorylation of human Bmi1 at Ser³¹⁶ by Akt impaired its function by triggering its dissociation from the Ink4a-Arf locus, which resulted in decreased ubiquitylation of histone H2A and the inability of Bmi1 to promote cellular proliferation and tumor growth. Moreover, Akt-mediated phosphorylation of Bmi1 also inhibited its ability to promote self-renewal of hematopoietic stem and progenitor cells. Our study provides a mechanism for the increased abundance of p16(Ink4a) and p19(Arf) seen in cancer cells with an activated phosphoinositide 3-kinase to Akt signaling pathway and identifies crosstalk between phosphorylation events and chromatin structure.
多梳抑制复合物蛋白 Bmi1 是编码细胞周期调控因子 p16(Ink4a)和肿瘤抑制因子 p19(Arf)的 Ink4a-Arf 基因座的转录沉默子。Bmi1 在肿瘤发生和干细胞自我更新中发挥着关键作用。我们的研究结果表明,Akt 通过磷酸化人 Bmi1 的丝氨酸 316 位,使其从 Ink4a-Arf 基因座上解离,从而降低组蛋白 H2A 的泛素化,并且 Bmi1 不能促进细胞增殖和肿瘤生长,从而损害了其功能。此外,Akt 介导的 Bmi1 磷酸化也抑制了其促进造血干细胞和祖细胞自我更新的能力。我们的研究为磷酸肌醇 3-激酶到 Akt 信号通路激活的癌细胞中 p16(Ink4a)和 p19(Arf)丰度增加提供了一种机制,并确定了磷酸化事件和染色质结构之间的串扰。
Transl Neurodegener. 2023-11-10
Cancer Metastasis Rev. 2023-6
Sci China Life Sci. 2023-5
Stem Cell Rev Rep. 2021-12
Cell Stem Cell. 2009-1-9
Cell Div. 2008-4-22
Curr Opin Cell Biol. 2008-4
Curr Opin Cell Biol. 2008-4